Developing and Refining an Acceptable Nordic Walking Intervention for People with Inflammatory Arthritis
Chief Investigator
|
Dates
|
Funding Stream
|
Amount
|
Melissa Domaille
|
Dec 2017 to Jul 2019
|
RCF Spring 2017
|
£17,112
|
Summary of work
The Nordic Walking (NW) intervention was co-developed with
patient research partners, rheumatology specialists and a NW
instructor. The intervention involved a 30-minute training session
followed by one-hour group sessions over ten weeks. The
intervention differed from standard NW in three key ways: (1)
initial training was provided by a NW instructor with support from
a rheumatology physiotherapist to small groups of 2 to 3,
facilitating an individualised approach; (2) a central base with
seats and drinking water was provided and flexible walking routes,
radiating to and from the central base enabled participants to
self-select their pace and distance; (3) an adapted warm-up and
cool-down suitable for people with inflammatory rheumatic
diseases.
Inclusion: adults with a confirmed diagnosis of an inflammatory
rheumatic disease (IRD) from University Hospitals Bristol NHS
Foundation Trust following informed consent.
The self-reported 36-item RAND Health Survey was selected as a
measure of health-related quality of life and was completed at
baseline and post-intervention. All participants took part in a
semi-structured audio-recorded focus group or interview
post-intervention to explore their experiences. Audio-recordings
were transcribed verbatim and analysed thematically.
Target recruitment was achieved (n=24: 18F:6M; mean age 60
years, range 35-82) N=13 had a diagnosis of rheumatoid arthritis
(RA), n=5 axial spondyloarthropathy, n=3 systemic vasculitis.
n=1 psoriatic arthritis, n=1 connective tissue disease (CTD) and
n=1 both RA and CTD.
Mean attendance was 8/10 sessions with 100% attendance at the
initial training and 79% attended the requested minimum of 5/10
group sessions.
RAND data suggested a trend towards improvement in the domains
of role functioning due to emotional limitations, energy/fatigue,
emotional well-being and general health. The qualitative data from
semi-structured interviews and focus groups provided insights into
the acceptability of the intervention. Preliminary findings
suggested emerging themes of 'enjoyment', 'learning a new skill',
'support from group', 'improvements in well-being' and 'physical
benefits'.
The results reveal the importance of this tailored approach to
NW. The individualised training session reassured participants that
the intervention was safe and the flexible route and ability to
self-select rests enabled participants to walk at their own pace
whilst remaining in sight of their peers and instructor. The
adapted warm-up and cool-down was an important part of the
intervention which participants reported as contributing
significantly to the benefits they experienced.
Participants said they would not join a standard NW group
following the intervention due to fear of holding up other walkers
or being 'stranded' if they experienced problems during the walk.
They reported enjoying learning a new skill and that their training
and development of technique continued throughout all 10 group
sessions.
Since taking part at least 10 of the 24 participants have
purchased NW poles to continue independently. Others said they
would keep NW in their 'repertoire' of physical activities to
potentially return to in the future. Barriers to continuing
included work commitments and the cost of purchasing NW poles.
This tailored delivery of NW has the potential to offer an
acceptable, beneficial and sustainable physical activity for people
with inflammatory rheumatic diseases.
The research team are currently preparing an NIHR Public Health
Research grant application to determine whether this intervention
is scalable and replicable and whether increased physical activity
is sustained after participating in this tailored NW programme.
Project outputs
Domaille M, Whybrow P, Carver E, Dures E, Greenwood R, Richards
P, Robson J, Stellinga R, Cramp F (2019) "Is a novel delivery of NW
acceptable for people with inflammatory rheumatic disease?" Rapid 5
platform presentation, Physio UK Conference, Birmingham, UK 1st-2nd
November
Domaille M, Whybrow P, Carver E, Dures E, Greenwood R, Richards
P, Robson J, Stellinga R, Cramp F (2019) "Is a novel delivery of NW
acceptable for people with inflammatory rheumatic disease?"
e-poster presentation, Public Health England Conference, Warwick
University, 10th-11th September
Domaille M, Whybrow P, Carver E, Dures E, Greenwood R, Richards
P, Robson J, Stellinga R, Cramp F (2019) "Is a novel delivery of NW
acceptable for people with inflammatory rheumatic disease?" Poster
presentation, Annual European Congress of Rheumatology (EULAR),
Madrid, Spain, 12th - 15th June
Domaille M, Whybrow P, Carver E, Dures E, Greenwood R, Richards
P, Robson J, Stellinga R, Cramp F (2019) "Is a novel delivery of NW
acceptable for people with inflammatory rheumatic disease?" Poster
presentation, British Society for Rheumatology Annual Conference,
Birmingham, UK April 30 - May 2
Main findings
A total of 24 people with inflammatory rheumatic diseases (IRD)
took part in this study and all 24 completed our questionnaires at
the end. We ran one group for 12 people from May to July 2018 and a
second group for 12 different people from September to November
2018. Everyone attended the initial training session and 79% of
people attended at least 5 out of the 10 group sessions.
What did we find?
The questionnaire results suggested a trend towards improvements
in fatigue, emotional well-being, and general health. At the focus
groups and interviews people told us that benefits they had
experienced included enjoyment, better posture, walking taller and
improved well-being. We were interested to discover how valuable
people had found the changes we had made to a standard NW group. We
heard that it was essential to have a central base to leave
valuables and for the route to be flexible. Being able to choose a
comfortable walking pace and be able to rest whenever needed helped
people to feel confident to take part. There were positive comments
about how adaptable the NW was to suit each individual and several
people liked learning a new skill. At least 10 people have told us
they have purchased their own NW poles since taking part in the
study and are continuing with this activity either by themselves,
with friends and family or with people they met during the
study.
In summary, we found that the tailored NW intervention we
developed was not only acceptable to people with IRD, but also has
the potential to be beneficial and sustainable in the longer
term.
Impact
There has been a lot of interest in NW from rheumatology teams
and physiotherapists in the UK. An article has been published on
the Chartered Society of Physiotherapy website
https://www.csp.org.uk/news/2018-12-11-study-finds-nordic-walking-could-help-inflammatory-rheumatic-diseases
and in the printed publication 'Frontline'.
The results were presented as a poster at the British Society of
Rheumatology Annual Conference in Birmingham in April 2019, the
Annual European Rheumatology Congress in Madrid in June 2019, the
Public Health England Conference in September 2019 and are due to
be presented at the Physio UK Conference in Birmingham in November
2019. This study has also won a Public Health Research Award for
Allied Healthcare Professions.
We are in the process of writing an application for funding for
a larger study where we can further test whether this tailored NW
intervention is beneficial, cost effective and sustainable for
people with IRD. We are also preparing a paper for publication in a
relevant, peer-reviewed journal.
In the longer term this tailored NW programme could be delivered
in partnership with local council exercise schemes and government
health walks making it cost-effective and sustainable. It may also
be beneficial to people with other long-term conditions which could
be investigated in a further study.
Updated 01/10/2019